Moreover, our present study revealed that CD36 inhibition attenuated the immune suppressive properties in OSCC-bearing hosts, suggesting that CD36 may be a potential biomarker for antitumour immune responses in oral cancer. Here, CD36 is linked to lip and oral cavity carcinoma.